Favipiravir vs no treatment, supportive treatment, or other antiviral treatment
All‐cause mortality – at 28 to 30 days, or in‐hospital · people with confirmed COVID‐19
It is very uncertain whether favipiravir changes all‐cause mortality – at 28 to 30 days, or in‐hospital compared with no treatment, supportive treatment, or other antiviral treatment (very low certainty).
1 finding from 1 review
- RR 0.84 [0.49, 1.46]11 studies · 3459 participantsVery low